NO20043376L - Medisinsk preparat som inneholder 2.2-diklor-12-(4-klorfenyl)dodekansyre - Google Patents

Medisinsk preparat som inneholder 2.2-diklor-12-(4-klorfenyl)dodekansyre

Info

Publication number
NO20043376L
NO20043376L NO20043376A NO20043376A NO20043376L NO 20043376 L NO20043376 L NO 20043376L NO 20043376 A NO20043376 A NO 20043376A NO 20043376 A NO20043376 A NO 20043376A NO 20043376 L NO20043376 L NO 20043376L
Authority
NO
Norway
Prior art keywords
chlorophenyl
dichloro
preparation containing
dodecanoic acid
medical preparation
Prior art date
Application number
NO20043376A
Other languages
English (en)
Norwegian (no)
Inventor
Toshio Inagi
Yasuo Shinoda
Shin-Ichiro Kobayashi
Niichiro Takano
Hiroyuki Kawashima
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20043376L publication Critical patent/NO20043376L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
NO20043376A 2002-01-16 2004-08-13 Medisinsk preparat som inneholder 2.2-diklor-12-(4-klorfenyl)dodekansyre NO20043376L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002007022 2002-01-16
PCT/JP2003/000251 WO2003059337A1 (en) 2002-01-16 2003-01-15 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Publications (1)

Publication Number Publication Date
NO20043376L true NO20043376L (no) 2004-08-13

Family

ID=19191302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043376A NO20043376L (no) 2002-01-16 2004-08-13 Medisinsk preparat som inneholder 2.2-diklor-12-(4-klorfenyl)dodekansyre

Country Status (20)

Country Link
US (1) US20060051410A1 (ru)
EP (1) EP1473033A1 (ru)
JP (1) JPWO2003059337A1 (ru)
KR (1) KR20040090975A (ru)
CN (1) CN1259909C (ru)
AU (1) AU2003201879B2 (ru)
BR (1) BR0307172A (ru)
CA (1) CA2474014A1 (ru)
EA (1) EA007650B1 (ru)
HR (1) HRP20040718A2 (ru)
IL (1) IL162880A0 (ru)
IS (1) IS7340A (ru)
MX (1) MXPA04006977A (ru)
NO (1) NO20043376L (ru)
NZ (1) NZ534471A (ru)
PL (1) PL373035A1 (ru)
TW (1) TWI252755B (ru)
UA (1) UA80270C2 (ru)
WO (1) WO2003059337A1 (ru)
ZA (1) ZA200406453B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004018634D1 (de) * 2003-05-23 2009-02-05 Kowa Co Carbonsäureverbindung und arzneimittel welches diese enthält
JPWO2005117853A1 (ja) * 2004-06-01 2008-04-03 興和株式会社 高脂血症治療剤及び糖尿病治療剤
EP1772149A1 (en) * 2004-07-27 2007-04-11 Kowa Company. Ltd. Drug for prevention or treatment of diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa

Also Published As

Publication number Publication date
CN1612730A (zh) 2005-05-04
CN1259909C (zh) 2006-06-21
TW200302079A (en) 2003-08-01
PL373035A1 (en) 2005-08-08
US20060051410A1 (en) 2006-03-09
MXPA04006977A (es) 2005-04-19
UA80270C2 (en) 2007-09-10
EA200400954A1 (ru) 2004-12-30
BR0307172A (pt) 2004-11-03
IL162880A0 (en) 2005-11-20
EA007650B1 (ru) 2006-12-29
WO2003059337A1 (en) 2003-07-24
KR20040090975A (ko) 2004-10-27
CA2474014A1 (en) 2003-07-24
AU2003201879B2 (en) 2007-09-13
AU2003201879A1 (en) 2003-07-30
IS7340A (is) 2004-06-30
TWI252755B (en) 2006-04-11
HRP20040718A2 (en) 2004-12-31
JPWO2003059337A1 (ja) 2005-05-19
NZ534471A (en) 2005-08-26
ZA200406453B (en) 2006-06-28
EP1473033A1 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
ITTO20010940A0 (it) ,,sedia,,
ATE516275T1 (de) Microbiozide (z.b. fungizide) 1,2,3- triazolderivate
NO20031273D0 (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
DE60322720D1 (de) Feste formulierungen enthaltend eine indolinon verbindung
NO20052975D0 (no) Nye 2',5'-oligoadenylsyreanaloger.
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
RU2002107079A (ru) Вещество, обладающее седативным действием
ATE369342T1 (de) 2,5-disubstituierte 3-mercaptopentansaure
NO20043376L (no) Medisinsk preparat som inneholder 2.2-diklor-12-(4-klorfenyl)dodekansyre
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
DE60216937D1 (de) INSEKTIZIDE 3 (2,6 DISUBSTITUIERTES PHENYL) 5 c4 ODER 5 ARYLTHIEN 2 ODER 3 YLÜ 1,2,4 TRIAZOLE
NO20041878D0 (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
ITRM20000106A0 (it) Composizione per la prevenzione e/o il trattamento di vascolopatie, che comprende propionil l-carnitina e coenzima q10.
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
MX245226B (es) Composicion insecticida que tiene estabilidad de almacenamiento mejorada.
DE50310743D1 (de) Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat
胡秋玲 I'll Try
ZA200306383B (en) Pharmaceutical formulation comprising bicalutamide.
ES1048757Y (es) Calzado perfeccionado.
Reinhart Mihūz latōdā’ayin lěPalestīnayīm’afīlū mezeg-’avīr
肖冉 Story B
ITMI20011226A0 (it) Connettore decentrabile per schneider pcs super-angulon 55mm 714.5
TR200000053A3 (tr) Dermatolojik preparat.
ES1048081Y (es) Calzado perfeccionado.
ES1048778Y (es) Calzado perfeccionado.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application